Trials In Focus

New Asia hub for Novotech Australian-based CRO Novotech is expanding into four new Asian markets with the establishment of a management hub in Kuala Lumpur. The hub will cover Novotech’s presence in Singapore, Thailand and the Philippines, adding to a joint venture presence in India and an office in Korea. “A sizeable patient population, transparent [...]

Trials In Focus

Novotech kicks off Dimebon trial Recruiting has begun for local sites in a Phase III international multi-centre study of the new Pfizer/Medivation Alzheimer’s hope Dimebon (Latrepirdine). CRO Novotech Which is running the CONCERT trial in Australia is looking to recruit patients with mild to moderate Alzheimer’s disease (AD) over eight sites, three in NSW, two [...]

ABC 720 Morning show, (Perth)

Interviewing Dr Roger Clarnette, from the McCusker Foundation, who is heading up the clincial trials in Perth for the CONCERT Study. Broadcast: 03/09/2009. Host: Geoff Hutchinson. About this interview: Dr. Roger Clarenette from the McCusker Foundation, who is heading up the clincial trials in Perth for the CONCERT Study, trialing a new Alzheimer’s drug called [...]

ABC1 News

Alzheimer’s Disease Trial Broadcast: 03/09/2009 Host: Geoff Hutchinson About this interview: Dr. Roger Clarenette from the McCusker Foundation, who is heading up the clincial trials in Perth for the CONCERT Study, trialing a new Alzheimer’s drug called dimebon. Dr Roger Clarnette talks about the drugs origins, the results from the study so far as well [...]

BRW

Biotech Trials plummet The number of clinical trials conducted for Australian biotechnology companies, usually by contract research organisations (CRO), has fallen by about 32 percent in the past year. For a licensed copy [CAL] of this article please email us at: team{at}onlinemediarooms.com Quote #1040

Pharma In Focus

Novotech’s success: Instant Update Sydney-based CRO, Novotech, is trumpeting its success despite the tight economic environment, announcing it attracted $22 million worth of new projects in the year to March. The company said it had been awarded 23 new multi-centre phase II and III clinical studies across a variety of therapeutic areas including oncology, ophthalmology, [...]

CenterWatch Weekly

Novotech in Joint Venture with Indian CRO, Focuses on Asian Expansion In keeping with its strategic focus on expanding in Asia, Australia-based contract research organization (CRO) Novotech has entered into a joint venture with ETI Klinical, a CRO based in Bangalore, India, and part of the Karle Group. Novotech already had, and will keep, its [...]

Applied Clinical Trials

Novotech Signs Joint Venture with Indian CRO ETI Klinical Novotech, a leading Australia based clinical research company, today announced it had entered into a strategic venture with ETI Klinical Pvt Ltd, part of the Karle Group of companies, a US $600 million Indian multinational. The joint venture designed to service the growing demand for global [...]

FierceBiotech

Novotech signs joint venture with Indian CRO ETI Klinical PVT Limited deal to drive more global clinical trials to India Novotech, a leading Australia based clinical research company, today announced it had entered into a strategic venture with ETI Klinical Pvt Ltd, part of the Karle Group of companies, a US $ 600 million Indian [...]

PharmAsia News

Aussie CRO Novotech Expands Asian Footprint With Indian ETI Joint Venture: An Interview With PharmAsia News The largest independent research organization in Australia, Sydney-based Novotech announced May 6 that it formed a joint venture with Bangalore-based ETI Klinical, which is part of the multinational Karle Group. With operations in Australia, New Zealand, the United States, [...]

« Previous Page — Next Page »